ATE533767T1 - Derivate aus n-heterozyklischen-6- heterozyklischen imidazo-ä1,2-aü-pyridin-2- carboxamiden, ihre herstellung und ihre therapeutische anwendung - Google Patents
Derivate aus n-heterozyklischen-6- heterozyklischen imidazo-ä1,2-aü-pyridin-2- carboxamiden, ihre herstellung und ihre therapeutische anwendungInfo
- Publication number
- ATE533767T1 ATE533767T1 AT08872982T AT08872982T ATE533767T1 AT E533767 T1 ATE533767 T1 AT E533767T1 AT 08872982 T AT08872982 T AT 08872982T AT 08872982 T AT08872982 T AT 08872982T AT E533767 T1 ATE533767 T1 AT E533767T1
- Authority
- AT
- Austria
- Prior art keywords
- heterocyclic
- carboxamides
- pyridine
- derivatives
- preparation
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/22—Tin compounds
- C07F7/2208—Compounds having tin linked only to carbon, hydrogen and/or halogen
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0800006A FR2925904B1 (fr) | 2008-01-02 | 2008-01-02 | DERIVES DE N-HETEROCYCLIQUE-6-HETEROCYCLIQUE-IMIDAZO°1,2-a! PYRIDINE-2-CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
PCT/FR2008/001838 WO2009106751A2 (fr) | 2008-01-02 | 2008-12-31 | Dérivés de n-heterocyclique-6-heterocyclique-imidazo[1,2- a]pyridiνe-2-carb0xamides, leur préparation et leur application en thérapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE533767T1 true ATE533767T1 (de) | 2011-12-15 |
Family
ID=39768560
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08872982T ATE533767T1 (de) | 2008-01-02 | 2008-12-31 | Derivate aus n-heterozyklischen-6- heterozyklischen imidazo-ä1,2-aü-pyridin-2- carboxamiden, ihre herstellung und ihre therapeutische anwendung |
Country Status (23)
Country | Link |
---|---|
US (1) | US20100317686A1 (de) |
EP (1) | EP2225243B1 (de) |
JP (1) | JP2011508762A (de) |
KR (1) | KR20100103660A (de) |
CN (1) | CN101959885A (de) |
AR (1) | AR070075A1 (de) |
AT (1) | ATE533767T1 (de) |
AU (1) | AU2008351929A1 (de) |
BR (1) | BRPI0821823A2 (de) |
CA (1) | CA2710794A1 (de) |
CL (1) | CL2008003929A1 (de) |
CO (1) | CO6331311A2 (de) |
EA (1) | EA201070818A1 (de) |
FR (1) | FR2925904B1 (de) |
IL (1) | IL206672A0 (de) |
MA (1) | MA32058B1 (de) |
MX (1) | MX2010007352A (de) |
PA (1) | PA8810201A1 (de) |
PE (1) | PE20091531A1 (de) |
TW (1) | TW200936133A (de) |
UY (1) | UY31590A1 (de) |
WO (1) | WO2009106751A2 (de) |
ZA (1) | ZA201004646B (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2925907B1 (fr) * | 2008-01-02 | 2010-10-15 | Sanofi Aventis | DERIVES DE 2-HETEROAROYL-IMIDAZO°1,2-a!PYRIDINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
WO2012147890A1 (ja) * | 2011-04-27 | 2012-11-01 | 持田製薬株式会社 | 新規アゾール誘導体 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004103991A1 (fr) * | 2003-05-20 | 2004-12-02 | 'chemical Diversity Research Institute', Ltd. | Piperidines 2-substituees, bibliotheque focalisee et composition pharmaceutique |
US7544803B2 (en) * | 2004-01-23 | 2009-06-09 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
EP1849465A4 (de) * | 2005-02-18 | 2008-12-24 | Takeda Pharmaceutical | Agens zur kontrolle der funktion des gpr34-rezeptors |
EP2457901A1 (de) * | 2005-03-14 | 2012-05-30 | High Point Pharmaceuticals, LLC | Benzazolderivate, Zusammensetzungen und Verfahren zur Verwendung als b-Sekretase-Inhibitoren |
TW200800997A (en) * | 2006-03-22 | 2008-01-01 | Astrazeneca Ab | Chemical compounds |
-
2008
- 2008-01-02 FR FR0800006A patent/FR2925904B1/fr not_active Expired - Fee Related
- 2008-12-23 PA PA20088810201A patent/PA8810201A1/es unknown
- 2008-12-30 UY UY31590A patent/UY31590A1/es not_active Application Discontinuation
- 2008-12-30 AR ARP080105780A patent/AR070075A1/es unknown
- 2008-12-30 CL CL2008003929A patent/CL2008003929A1/es unknown
- 2008-12-30 PE PE2008002194A patent/PE20091531A1/es not_active Application Discontinuation
- 2008-12-31 EA EA201070818A patent/EA201070818A1/ru unknown
- 2008-12-31 TW TW097151696A patent/TW200936133A/zh unknown
- 2008-12-31 AT AT08872982T patent/ATE533767T1/de active
- 2008-12-31 BR BRPI0821823-4A patent/BRPI0821823A2/pt not_active IP Right Cessation
- 2008-12-31 MX MX2010007352A patent/MX2010007352A/es active IP Right Grant
- 2008-12-31 EP EP08872982A patent/EP2225243B1/de active Active
- 2008-12-31 AU AU2008351929A patent/AU2008351929A1/en not_active Abandoned
- 2008-12-31 WO PCT/FR2008/001838 patent/WO2009106751A2/fr active Application Filing
- 2008-12-31 KR KR1020107017145A patent/KR20100103660A/ko not_active Application Discontinuation
- 2008-12-31 JP JP2010541087A patent/JP2011508762A/ja not_active Withdrawn
- 2008-12-31 CN CN2008801277673A patent/CN101959885A/zh active Pending
- 2008-12-31 CA CA2710794A patent/CA2710794A1/fr not_active Abandoned
-
2010
- 2010-06-28 IL IL206672A patent/IL206672A0/en unknown
- 2010-07-01 US US12/828,376 patent/US20100317686A1/en not_active Abandoned
- 2010-07-01 ZA ZA2010/04646A patent/ZA201004646B/en unknown
- 2010-07-02 CO CO10080869A patent/CO6331311A2/es not_active Application Discontinuation
- 2010-08-02 MA MA33056A patent/MA32058B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
FR2925904B1 (fr) | 2010-01-01 |
AR070075A1 (es) | 2010-03-10 |
IL206672A0 (en) | 2010-12-30 |
FR2925904A1 (fr) | 2009-07-03 |
MX2010007352A (es) | 2010-08-18 |
CL2008003929A1 (es) | 2010-01-22 |
BRPI0821823A2 (pt) | 2015-06-16 |
US20100317686A1 (en) | 2010-12-16 |
EP2225243B1 (de) | 2011-11-16 |
WO2009106751A2 (fr) | 2009-09-03 |
TW200936133A (en) | 2009-09-01 |
EA201070818A1 (ru) | 2011-02-28 |
UY31590A1 (es) | 2009-08-03 |
CA2710794A1 (fr) | 2009-09-03 |
EP2225243A2 (de) | 2010-09-08 |
CN101959885A (zh) | 2011-01-26 |
PE20091531A1 (es) | 2009-10-29 |
AU2008351929A1 (en) | 2009-09-03 |
PA8810201A1 (es) | 2009-08-26 |
CO6331311A2 (es) | 2011-10-20 |
WO2009106751A3 (fr) | 2010-02-25 |
KR20100103660A (ko) | 2010-09-27 |
MA32058B1 (fr) | 2011-02-01 |
JP2011508762A (ja) | 2011-03-17 |
ZA201004646B (en) | 2011-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE467633T1 (de) | 2-aryl-6-phenylimidazoä1,2-aüpyridin-derivate, ihre herstellung und therapeutische verwendung | |
DE602007005487D1 (de) | Harnstoffderivate von tropan, ihre herstellung und ihre therapeutische anwendung | |
FR2926553B1 (fr) | Derives d'indole-2-carboxamides et d'azaindole-2- carboxamides substitues par un groupe silanyle, leur preparation et leur application en therapeutique | |
NO345064B1 (no) | Anvendelse av kombinasjonslegemidler, omfattende antimykotika | |
HK1159108A1 (en) | Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof | |
DE602005019743D1 (de) | Oxopiperidinderivate, ihre herstellung und therapeutische verwendung | |
ATE502035T1 (de) | 2-amido-4-phenylthiazol-derivate, ihre herstellung und ihre therapeutische verwendung | |
ATE512970T1 (de) | Dimere von artemisininderivaten, deren herstellung und deren therapeutische verwendung | |
BRPI0807078A2 (pt) | Composto, e, formulação farmacêutica | |
PL2238110T3 (pl) | Pochodne 5,6-bisarylo-2-pirydyno-karboksamidu, ich wytwarzanie i ich zastosowanie terapeutyczne jako antagonistów receptora Urotensyny II | |
ATE540023T1 (de) | Neuartige 3-aminoalkyl-1,3-dihydro-2h-indol-2-on- derivate, ihre herstellung und therapeutische verwendung | |
DE602006005246D1 (de) | Pyridoä2,3-düpyrimidin-derivate sowie deren herstellung und therapeutische anwendung | |
DE602007014179D1 (de) | Herstellung von polytrimethylen-etherglykol | |
BRPI0915527A2 (pt) | pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos | |
ATE548349T1 (de) | In stellung 3 disubstituierte indol-2-on- pyridinderivate, ihre herstellung sowie ihre therapeutische anwendung | |
ZA201103516B (en) | Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof | |
DE602006015675D1 (de) | 6-heteroarylpyridoindolon-derivate, ihre herstellung und ihre therapeutische anwendung | |
DE602008005536D1 (de) | Herstellung von MnB12H12 | |
ATE499351T1 (de) | Aryl- und heteroaryl-ethyl-acylguanidinderivate, ihre herstellung und ihre therapeutische anwendung | |
ATE520654T1 (de) | Polypyrrol-derivate, ihre herstellung und ihre therapeutische verwendung | |
DK2310383T3 (da) | 2-oxo-alkyl-1-piperazin-2-onderivater, fremstilling deraf og terapeutisk anvendelse deraf | |
DE102008002364A8 (de) | Ru-Sulfoxid-Komplexe, deren Herstellung und Verwendung | |
ATE549339T1 (de) | Derivate von pyrrolopyridin-2-carboxamiden, ihre herstellung und ihre therapeutische anwendung | |
DK2234966T3 (da) | Azetidinderivater, fremstilling og terapeutisk anvendelse heraf | |
ATE524468T1 (de) | Derivate aus n-phenyl-imidazo-(1,2-a)-pyridin-2- carboxamiden, ihre herstellung sowie ihre therapeutische anwendung |